4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 4
Accession 0000899243-21-031393
CIK 0001861560other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 8:01 PM ET
Size
7.4 KB
Accession
0000899243-21-031393
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Transactions
- Conversion
Series B Preferred Stock
2021-08-02−4,831,384→ 0 total→ Class A Common Stock (897,671 underlying) - Conversion
Class A Common Stock
2021-08-02+897,671→ 897,671 total
Footnotes (1)
- [F1]Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock automatically converted into 0.1858 shares of the Issuer's Class A Common Stock. The Series B Preferred Stock had no expiration date.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001787092
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 8:01 PM ET
- Size
- 7.4 KB